StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

ENDRA Life Sciences's revenue for the twelve months ending Dec 31, 2019 was $0, down 100.0% year over year. For fiscal 2020 it was $0. The highest annual figure on record is $515.58K in fiscal 2016.

Annual revenue

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$6.17K-98.2%
FY2017Dec 31, 2017$351.62K-31.8%
FY2016Dec 31, 2016$515.58K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0-100.0%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$6.17K–
Q4 FY2017Dec 31, 2017$6.85K-98.7%
Q3 FY2017Sep 30, 2017$287.00K–
Q2 FY2017Jun 30, 2017$57.77K–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$515.58K–
Q3 FY2016Sep 30, 2016$0–

More ENDRA Life Sciences figures

See a number that looks wrong?